Recent Finacing
Recent Raise
Solstice Biologics develops proprietary delivery technology, licensed from UCSD, to enable short double-stranded RNAi and microRNA molecules to cross cell membranes across multiple cell types for nucleic acid therapeutics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors